Apoptosis in breast cancer: Relationship with other pathological parameters

Endocrine-Related Cancer

Volumn 6, Issue 1, 1999, Pages 13-16

  Lipponen, P ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ANALYTIC METHOD; APOPTOSIS; AXILLARY LYMPH NODE; BREAST CANCER; BREAST DUCT; CANCER INVASION; CELL COUNT; CELL PROLIFERATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PROGNOSIS; REVIEW; STAINING;

ANEUPLOIDY; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE PROGRESSION; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; GENES, P53; HUMANS; KI-67 ANTIGEN; MITOTIC INDEX; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PROGESTERONE; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CELL SURFACE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032920451     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0060013     Document Type: Review

References (23)

1. Berardo MD, Elledge RM, de Moor C, Clark GM, Osborne CK & Allred DC 1998 Bcl-2 and apoptosis in lymph node positive breast carcinoma. Cancer 82 1296-1302.
2. Bloom HSG & Richardson WW 1957 Histological grading and prognosis in breast cancer. British Journal of Cancer 11 359-377.
3. Buja LM, Eigenbrodt ML & Eigenbrodt EH 1993 Apoptosis and necrosis. Basic types of cell death. Archives of Pathology and Laboratory Medicine 117 1208-1214.
4. Ellis PA, Smith IE, Detre S, Burton SA, Salter J, A'Hern R, Walsh G, Johnston SRD & Dowsett M 1998 Reduced apoptosis and proliferation and increased bcl-2 in residual breast cancer following preoperative chemotherapy. Breast Cancer Research and Treatment 48 107-116.
5. Grekou AN, Toliou T, Stravoravdi P, Patakiouta F, Tsoukalas T, Pinakidis M & Keramidas G 1996 Correlation of apoptosis with the distribution and composition of lymphocytic infiltrate in human breast carcinomas. Anticancer Research 16 3991-3996.
6. Harn H-J, Shen KL, Yueh KC, Ho LI, Yu JC, Chiu SC & Lee WH 1997 Apoptosis occurs more frequently in intraductal carcinoma than in infiltrating duct carcinoma of human breast cancer and correlates with altered p53 expression: detected by terminal-deoxynucleotidyl-transferase-mediated dUTP-FITC nick end labelling (TUNEL). Histopathology 31 534-539.
7. Hassan HI & Walker RA 1998 Decreased apoptosis in non-involved tissue from cancer-containing breasts. Journal of Pathology 184 258-264.
8. Hockenbery DM 1992 The bcl-2 oncogene and apoptosis. Seminars in Immunology 4 413-420.
9. Koskinen PJ & Alitalo K 1993 Role of myc amplification and over-expression in cell growth, differentiation and death. Seminars in Cancer Biology 4 3-12.
10. Lipponen P & Aaltomaa S 1994 Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. Journal of Pathology 173 333-340.
11. Lipponen P, Aaltomaa S, Kosma V-M & Syrjänen K 1994 Apoptosis in breast cancer as related to histopathological characteristics and prognosis. European Journal of Cancer 30A 2068-2073.
12. Lipponen P, Pietiläinen T, Kosma V-M, Aaltomaa S, Eskelinen M & Syrjänen K 1995 Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. Journal of Pathology 177 49-55.
13. Mustonen M, Taunio H, Pääkkö P & Soini Y 1997 The extent of apoptosis is inversely associated with bcl-2 expression in premalignant and malignant breast lesions. Histopathology 31 347-353.
14. Pietiläinen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma V-M & Syrjänen K 1995 Expression of p53 protein has no independent prognostic value in breast cancer. Journal of Pathology 177 225-232.
15. Pietiläinen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma V-M & Syrjänen K 1996 The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer. Journal of Cancer Research and Clinical Oncology 122 687-692.
16. Samoszuk MK, Sallash G, Chen K, Carlton E & Oldakrt T 1996 Association between flow cytometric S-phase fraction and apoptotic rate in breast cancer. Cytometry 26 281-285.
17. Searle J, Kerr JFR & Bishop CJ 1982 Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathology Annals 17 229-259.
18. Shen K-L, Harn H-J, Ho L-L, Yu C-P, Chiu S-C & Lee W-H 1998 The extent of proliferative activity and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by Ki-67 labelling and terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labelling. Cancer 82 2373-2381.
19. van Slooten H-J, van der Vijver MJ, van der Velde CJH & van Dierendonck JH 1998 Loss of bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity. British Journal of Cancer 77 789-796.
20. Staunton MJ & Gaffney EF 1995 Tumor type is determinant of susceptibility to apoptosis. American Journal of Clinical Pathology 103 300-307.
21. Wyllie AH 1992 Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer and Metastasis Reviews 11 95-103.
22. Zhang G-J, Kimijima I, Abe R, Watanabe T, Kanno M, Hara K & Tsuchiya A 1998 Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers. Anticancer Research 18 1989-1997.
23. Zheng WQ & Zhan RZ 1998 Quantitative comparison of apoptosis to cell proliferation and p53 protein in breast carcinomas. Analytical and Quantitative Cytology and Histology 20 1-6.